Ignite Creation Date:
2025-12-25 @ 1:26 AM
Ignite Modification Date:
2025-12-27 @ 11:17 PM
Study NCT ID:
NCT00694993
Status:
COMPLETED
Last Update Posted:
2017-08-10
First Post:
2008-06-09
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Single and Repeat Dose First Time in Human Study for an Intranasal H1/H3 Dual Antagonist in Healthy Male Subjects
Sponsor:
GlaxoSmithKline
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2007-12-17
Start Date Type:
ACTUAL
Primary Completion Date:
2008-05-26
Primary Completion Date Type:
ACTUAL
Completion Date:
2008-05-26
Completion Date Type:
ACTUAL
First Submit Date:
2008-06-09
First Submit QC Date:
None
Study First Post Date:
2008-06-11
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-08-09
Last Update Post Date:
2017-08-10
Last Update Post Date Type:
ACTUAL